143 related articles for article (PubMed ID: 14756541)
1. Functional relationship and gene ontology classification of breast cancer biomarkers.
Arciero C; Somiari SB; Shriver CD; Brzeski H; Jordan R; Hu H; Ellsworth DL; Somiari RI
Int J Biol Markers; 2003; 18(4):241-72. PubMed ID: 14756541
[TBL] [Abstract][Full Text] [Related]
2. Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.
Ghilli M; Mariniello MD; Scatena C; Dosa L; Traficante G; Tamburini A; Caporalini C; Buccoliero AM; Facchini F; Colizzi L; Quattrini Li A; Landucci E; Manca G; Naccarato AG; Caramella D; Favre C; Roncella M
Breast Cancer Res Treat; 2018 Aug; 170(3):445-454. PubMed ID: 29616377
[TBL] [Abstract][Full Text] [Related]
3. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
4. Biomarker Studies in Early Detection and Prognosis of Breast Cancer.
Li G; Hu J; Hu G
Adv Exp Med Biol; 2017; 1026():27-39. PubMed ID: 29282678
[TBL] [Abstract][Full Text] [Related]
5. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
6. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
7. Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.
Yuan P; Liu D; Deng M; Liu J; Wang J; Zhang L; Liu Q; Zhang T; Chen Y; Jin G
Pathol Oncol Res; 2015 Apr; 21(2):469-75. PubMed ID: 25408372
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of breast cancers.
Curtis C
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
[TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of breast cancer: what the pathologist needs to know.
Rakha EA; Green AR
Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
[TBL] [Abstract][Full Text] [Related]
11. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
Nassar FJ; Nasr R; Talhouk R
Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
14. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
15. Multigene prognostic tests in breast cancer: past, present, future.
Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
18. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
19. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
20. The Significance of Proteomic Biomarkers in Male Breast Cancer.
Zografos E; Gazouli M; Tsangaris G; Marinos E
Cancer Genomics Proteomics; 2016; 13(3):183-90. PubMed ID: 27107060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
